Proposed experiment from debate on Perivascular spaces and glymphatic clearance failure in AD

SUMMARY

# Proposed experiment from debate on Perivascular spaces and glymphatic clearance failure in AD ## Background and Rationale This experiment examines the role of PDGFR-β signaling in perivascular space dynamics and its impact on glymphatic clearance failure in Alzheimer's disease using advanced imaging approaches. Platelet-derived growth factor receptor-β (PDGFR-β) is expressed by pericytes and plays a crucial role in blood-brain barrier integrity and perivascular space maintenance. Dysfunction o

METHODOLOGY NOTES

**Phase 1: Cell Culture Preparation (Days 1-7)** • Establish primary human brain pericyte cultures (n=6 cultures per condition) from commercially available sources • Seed cells at 2×10^4 cells/cm² in PDL-coated imaging dishes • Maintain in pericyte medium (ScienCell) with 2% FBS for 5-7 days until confluence • Transfect with fluorescent markers (mCherry-α-SMA for pericyte identification) • Prepare co-culture systems with human cerebral microvascular endothelial cells (HCMEC/D3) at 1:2 pericyte:endothelial ratio **Phase 2: PDGFR-β Pathway Modulation (Days 8-10)** • Design and validate biased agonists targeting PI3K (compound A, 10-100 nM) vs MAPK (compound B, 10-100 nM) downstream of PDGFR-β • Treat cultures with: vehicle control, PDGF-BB (10 ng/ml), PI3K-biased agonist, MAPK-biased agonist, combination treatments • Perform dose-response curves (0.1-1000 nM) for each compound • Validate pathway selectivity via Western blot for p-AKT (PI3K) and p-ERK1/2 (MAPK) at 15min, 1h, 4h, 24h **P